Print

Human Genome Sciences, Inc. (HGSI) Asks FDA to Approve Anthrax Drug ABthrax  
5/21/2009 7:58:24 AM

AP -- Human Genome Sciences Inc. said Thursday it asked the Food and Drug Administration to approve ABthrax, a drug it is developing to treat inhaled anthrax.
//-->